Ultimately, meaningful value assessment is going to require unbiased comparisons between competing strategies. Decision models are extremely useful in this regard and can provide important insight into cost-effectiveness evaluations.
Oncology Vol 31 No 4
Advertisement
Advertisement
Trending on CancerNetwork
1
KRd-Based Quadruplets May “Eliminate” Transplant Need for Multiple Myeloma
2
KRd Appears to Exhibit Greater Outcomes in Standard-Risk Multiple Myeloma
3
Creating a “Watershed Moment” for Novel Therapeutic Access in Lymphoma
4
ADCE-D01 Earns FDA Fast Track Designation in Soft Tissue Sarcoma
5
